Source:http://linkedlifedata.com/resource/pubmed/id/16705566
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2006-5-17
|
pubmed:abstractText |
The use of daptomycin has been associated with an elevation in creatine phosphokinase level, with a reported incidence of 2.8% in phase III clinical trials. Published case reports have documented the presence of myopathy in patients who received daptomycin; however, there have been no previously reported cases of rhabdomyolysis in animals or humans to date. We describe a case of rhabdomyolysis during therapy with daptomycin.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1537-6591
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e108-10
|
pubmed:meshHeading |
pubmed-meshheading:16705566-Anti-Bacterial Agents,
pubmed-meshheading:16705566-Daptomycin,
pubmed-meshheading:16705566-Enterococcus faecium,
pubmed-meshheading:16705566-Female,
pubmed-meshheading:16705566-Gram-Positive Bacterial Infections,
pubmed-meshheading:16705566-Humans,
pubmed-meshheading:16705566-Middle Aged,
pubmed-meshheading:16705566-Rhabdomyolysis
|
pubmed:year |
2006
|
pubmed:articleTitle |
Rhabdomyolysis during therapy with daptomycin.
|
pubmed:affiliation |
Department of Pharmacy, University of Kentucky Chandler Medical Center, Lexington, Kentucky 40536, USA. spapa2@email.uky.edu
|
pubmed:publicationType |
Journal Article,
Case Reports
|